Etiket: CureVac
NASDAQ title CureVac shares lower again after record low: Evercore analyst sees good basis for appeal in BioNTech legal dispute
After the previous day’s record low, CureVac’s shares attempted to stabilize on Wednesday. At a time of 4.2997 euros, the vaccine manufacturer’s papers in NASDAQ trading broke away from the…
NASDAQ value CureVac share falls by over 30 percent: CureVac suffers a setback in the vaccine patent dispute with BioNTech
The Federal Patent Court has declared a basic corona vaccine patent from the Tübingen pharmaceutical company CureVac invalid. The shares of the Tübingen company CureVac then lost a good third…
CureVac shares on the NASDAQ under pressure: CureVac is investing up to 150 million euros in a new facility
According to a newspaper report, the Tübingen biotech company CureVac is investing between 100 and 150 million euros in its planned new production facility. This is reported by the “Stuttgarter…
Novavax, Moderna, BioNTech, CureVac & Co: Pandemic doesn’t take a break – waiting for autumn
shares in this article by Julia Groß, €uro on Sunday WWhilst the stream of visitors in the remaining German vaccination centers is rather sparse, a booking website for the…